Skip to main content

Not investment advice.Read full disclaimer

Healthcare · Drug Manufacturers - Specialty & Generic

52W Range

54thpctl

Volume

0.77×avg

Market Cap

10.43MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Continue with finqOS

Get the full profile on Agile Therapeutics, Inc.

Executive team, business description, key stats, and everything you need to understand the company.

Start Free Trial→Sign In

14-day free trial · No credit card required

Agile Therapeutics, Inc.

AGRXNASDAQ Capital Market·USD·Closed

Agile Therapeutics, Inc.

AGRXNASDAQ·USD·Closed

$1.51

+3.42%

$1.51

+$0.05 (3.42%)

52W Range

54thpctl

Volume

0.77×avg

Mkt Cap

10.43MUSD

P/E

-0.2TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

AGRX: Agile Therapeutics, Inc. Company Profile & Overview | finqOS